DJIA Rises 5.62% This Quarter to 39807.37 — Data Talk
The Dow Jones Industrial Average is up 2117.83 points or 5.62% this quarter to 39807.37
--Up for two consecutive quarters
--Up 6299.87 points or 18.80% over the last two quarters
--Largest two-quarter percentage gain since the 3rd quarter 2020
--Up five of the past six quarters
--This month it is up 810.98 points or 2.08%
--Up for five consecutive months
--Up 6754.50 points or 20.44% over the last five months
--Largest five-month percentage gain since March 2021
--Longest winning streak since Aug. 2020 when the market rose for five straight months
--This week it is up 331.47 points or 0.84%
--Up for two consecutive weeks
--Up 1092.60 points or 2.82% over the last two weeks
--Largest two-week point and percentage gain since the week ending Dec 22, 2023
--Today it is up 47.29 points or 0.12%
--A new record close
--17th record close of 2024
--Up for two consecutive trading days
--Up 525.04 points or 1.34% over the last two trading days
--Largest two-day point and percentage gain since Thursday, March 21, 2024
--Up 44.86% from the Election Day close of 27480.03 on Tuesday, Nov. 3, 2020
--Up 27.64% from the Inauguration Day close of 31188.38 on Wednesday, Jan. 20, 2021
--Up 22.80% from its 52-week low of 32417.59 hit Friday, Oct. 27, 2023
--Rose 21.15% from 52 weeks ago
--Up 6.82% from its 2024 closing low of 37266.67 hit Wednesday, Jan. 17, 2024
--Year-to-date it is up 2117.83 points or 5.62%
Data based on preliminary market closing values
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 28, 2024 16:33 ET (20:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand